NCT03234816View on ClinicalTrials.gov

Vasopressor Prophylaxis After Spinal Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

August 2, 2017

Primary Completion Date

November 2, 2018

Study Completion Date

December 10, 2018

Conditions
Cesarean Section Complications
Interventions
DRUG

Norepinephrine 0.05 mcg /Kg/min

Norepinephrine infusion by rate of 0.05 mcg /Kg/min after spinal anesthesia

DRUG

Norepinephrine 0.1 mcg /Kg/min

Norepinephrine infusion by rate of 0.05 mcg /Kg/min after spinal anesthesia

DRUG

Norepinephrine 0.15 mcg /Kg/min

Norepinephrine infusion by rate of 0.05 mcg /Kg/min after spinal anesthesia

DRUG

Bupivacaine

10 mg Bupivacaine intra-thecal for spinal anesthesia

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03234816 - Vasopressor Prophylaxis After Spinal Anesthesia | Biotech Hunter | Biotech Hunter